A carregar...

Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model

Sunitinib, a multitargeted oral tyrosine kinase inhibitor, used widely to treat solid tumors, results in hypertension in up to 47% and left ventricular dysfunction in up to 19% of treated individuals. The relative contribution of afterload toward inducing cardiac dysfunction with sunitinib treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JACC Basic Transl Sci
Main Authors: Truitt, Rachel, Mu, Anbin, Corbin, Elise A., Vite, Alexia, Brandimarto, Jeffrey, Ky, Bonnie, Margulies, Kenneth B.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059907/
https://ncbi.nlm.nih.gov/pubmed/30062212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.12.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!